Materials and methods

Criteria for Considering Studies for This Review
All published, unpublished, and ongoing randomized trials reporting data that compare outcomes for women undergoing ET through the cervical route after IVF, or ICSI, using ultrasound-guided versus the clinical touch method were sought in all languages.
Types of Outcome Measures
The primary outcome measures were the live-birth, ongoing pregnancy, and clinical pregnancy rates. The secondary outcomes were the implantation, multiple pregnancies, and miscarriage rates. In addition, the incidences of ectopic pregnancies, difficult or failed transfers, and need for instrumental assistance during the transfer (e.g., stylette, tenaculum, dilatation, sounding), were evaluated. Last, the tips of the posttransfer catheters were evaluated for signs of cervical or endometrial trauma (e.g., presence of blood, mucus, or both), in addition to retained embryos.
Search Strategy for Identification of Studies
Meticulous computerized searches (last performed July 2006) were conducted by using MEDLINE (1966 to present); EMBASE (1980 to present); the Cochrane Central Register of Controlled Trials (CENTRAL) on the Cochrane Library issue 3, 2006 ; the National Research Register; the trial register of controlled trials (www.controlled-trials.com); the Latin American and Caribbean Health Sciences Literature database (LILACS); and details on reviews in progress collected by the National Health Service Centre for Reviews and Dissemination. Furthermore, the reference lists of all known primary studies, review articles, citation lists of relevant publications, abstracts of major scientific meetings (e.g., European Society of Human Reproduction and Embryology and American Society for Reproductive Medicine), and included studies were examined to identify additional relevant citations. Finally, ongoing and unpublished trials were sought by contacting experts in the field and commercial entities.
Methods of the Review
A standardized data extraction form was developed and pilot tested for consistency and completeness. Trials were considered for inclusion, and trial data extracted. Data management and statistical analyses were conducted by using the Review Manager 4.2, Meta-analysis With Interactive Explanations 1.2, and Power and Sample Size Calculations 2.1.30 statistical software packages. Individual outcome data were included in the analysis if they met the prestated criteria. Where possible, data were extracted to allow for an intention-to-treat analysis, defined as including in the denominator all randomized cycles. If data from the trial reports were insufficient or missing, the investigators of individual trials were contacted via E-mail for additional information, to perform analyses on an intention-to-treat basis. A response was received from the correspondence authors of nine trials (9) (10) (11) (12) (13) (14) (15) (16) (17) , with two providing the unpublished live-birth rates (11, 14) . For the meta-analysis, the number of participants experiencing the event in each group of the trial was recorded. Statistical heterogeneity of the included studies was determined by visual inspection of the outcome tables and more formally by using the ǒ 2 and I 2 tests for heterogeneity. The I 2 test is a statistical measure used to identify and quantify heterogeneity. It describes the percentage of the variability in effect estimates that is due to heterogeneity rather than sampling error (chance) (18) . An I 2 value greater than 50% may be considered to represent substantial heterogeneity. Meta-analysis of binary data was performed with the Mantel-Haenszel method and a fixed-effect model, and the odds ratio (OR) and 95% confidence intervals (95% CI) evaluated. Subsequently a sensitivity analysis was conducted by using the random-effects model. Furthermore, where appropriate, subgroup analyses were performed.
Search Results
A total of 25 prospective randomized controlled trials were identified (13 full-text papers, 11 conference abstracts, and one unpublished study) ( Fig. 1 ). Of these, three studies (19) (20) (21) were excluded initially for duplicate publication (i.e., published as abstract in a conference proceeding and as full text in a peer-reviewed journal). In addition, two trials (10, 12) were excluded because no data were available for review. Finally, the methodologic quality of the remaining 20 trials was assessed and data extracted to allow for an intention-to-treat analysis ( Table 1) .
Results
Primary Outcome Measures
With regard to the primary outcome measures, there was a significantly increased chance of a live birth (ultrasonography: 76/305 vs. clinical touch: 49/310, OR = 1.78, 95% CI = 1.19 to 2.67), an ongoing pregnancy (ultrasonography: 656/1,902 vs. clinical touch: 557/2,065, OR = 1.51, 95% CI = 1.31 to 1.74), and clinical pregnancy (ultrasonography: 1086/2,941 vs. clinical touch: 884/3,027, OR = 1.50, 95% CI = 1.34 to 1.68) with ultrasound guidance than with the standard clinical touch method ( Figure 2 , Figure 3 , Figure 4 ). Moreover, subgroup analyses of only the truly randomized trials, fresh nondonor cycles, and the frozen embryo replacement cycles revealed similar results ( Table 2 ). Even so, patients undergoing oocyte donor cycles did not demonstrate any significant findings between the ultrasound-guided and the clinical touch groups. Nevertheless, it is important to note that only one trial used oocyte donor cycles.
Secondary Outcome Measures
As for the secondary outcome measures, there was a significant increased chance of embryo implantation after ultrasound guidance compared with the standard clinical touch method (ultrasonography: 974/5,662 vs. clinical touch: 810/5,841, OR = 1.35, 95% CI = 1.22 to 1.50). Even so, there were similar rates of multiple pregnancies, ectopic pregnancies, and spontaneous miscarriages in the two groups (P>.05). As for the ease of transfer and the need for instrumental assistance, there was a statistically significant increased chance of having a difficult transfer, need for instrumental assistance, and failure to transfer with the assigned catheter during clinical touch alone compared with ultrasound guidance (Table 2 ). Even so, there was significant heterogeneity between the study trials: ease of transfer (ǒ 2 = 53.06, I 2 = 83.0%, P<.00001); need for instrumental assistance (ǒ 2 = 57.83, I 2 = 89.6%, P<.00001); failure to transfer with the assigned catheter (ǒ 2 = 2.92, I 2 = 65.8%, P<.09). Therefore, a series of sensitivity analyses were undertaken. The results of these analyses could only confirm the increased usage of instrumental assistance with the clinical touch group compared with the ultrasound-guided group (P=.04). The remaining comparisons could not be verified.
Finally, the catheter tips were evaluated for the presence of blood, mucus, and/or retained embryos. There were no significant differences for these rates between the two groups with the exception of increased incidence of finding blood on the catheter tips after clinical touch ET.
Discussion
Although most patients who undergo assisted procreation, via IVF or ICSI, will reach the ET stage with good-quality embryos available for replacement, embryo implantation remains the rate-limiting step in the success of this form of therapy. The aim of the ET procedure is to place embryos atraumatically and accurately within the uterus to allow for proper implantation and fetal development. Studies have shown that different factors may be involved in a successful transfer. These include ET catheter choice (4, 5) , the use of ultrasound guidance (35, 36) , the experience of the physician (37) , the ease of the procedure (3), the presence or absence of blood on the catheter (38) , the use of cervical introducers or obturators (39) , the value of resting after transfer (40) , the position of embryo insertion in the uterus (41, 42) , and retention of embryos in the catheter (43) . To ascertain the importance of each step involved in the ET procedure, individual factors must be evaluated independently. Therefore, the ET procedure may be divided arbitrarily into four distinct sections: [1] preparation before ET (e.g., patient position, cervical preparation, uterine position, and the dummy ET); [2] technical aspects related to the ET catheter (e.g., catheter type and catheter loading); [3] the ET procedure (e.g., the site of embryo deposition within the uterus and techniques to assist with the accurate placement of the embryo within the uterus; and [4] posttransfer aspects (e.g., expulsion of fluid/embryos from the cervix after ET and bed rest after ET) (44) . Because it would be difficult to compare several factors accurately at the same time, we decided to concentrate on one factor, the beneficial value of ultrasound guidance to guide catheter placement during the ET procedure. All the studies retrieved from our search have examined the role of twodimensional (2-D) transabdominal ultrasound guidance during ET. Even so, vaginal ultrasound-guided ET (40, 45) , as well as the use of threedimensional (46) and fourth-dimensional ultrasound-guided ET have been reported. Nonetheless, it is important to mention that to the best of our knowledge there are no randomized controlled trials comparing any of these new modalities either with the standard clinical touch method or with the 2-D ultrasound-guided method. Systematic reviews and meta-analysis of randomized controlled trials have proved to be the highest level of evidence in the hierarchy of medical knowledge. Even so, publication and search biases may confound the results of any systemic review, because studies showing positive results are more likely to be published (47, 48) . Therefore, every effort has been made to avoid bias by searching a wide variety of online databases (with no language barriers), hand searching of the gray literature, and contacting commercial entities in search of unpublished or ongoing trials. The objective was to minimize the chance of publication or selection bias to strengthen the validity of the results of the systematic review. Failure to identify trials reported in conference proceedings might affect the results or threaten the validity of a systematic review (49) . In addition, multiple methods were used to detect publication, location, or selection biases including funnel plot, trim and fill funnel plot, and the Egger regression analyses (50) . The funnel plot is a graphic display of study precision plotted against the effect size. It is used to investigate whether there is a link between study size and treatment effect. The funnel plot of the included studies shows asymmetry that may be due to publication bias. Even so, it is important to note that there may be other etiologies for the asymmetry found in funnel plot, including selection biases (e.g., location biases, language bias, citation bias, multiple publication bias), poor methodologic quality of smaller studies (e.g., poor methodologic design, inadequate analysis, fraud), true heterogeneity (i.e., size of effect differs according to study size), artifactual, and just by chance (51). Duval and Tweedie (52) have proposed the "trim and fill" method for defining the extent of publication bias. It is based on adding studies to a funnel plot so that it becomes symmetrical. Then the smaller studies are omitted until the funnel plot is symmetrical (trimming). The trimmed funnel plot is used to estimate the true "center" of the funnel, and then the omitted studies and their missing "counterparts" around the center are replaced (filling). This provides an estimate of the number of missing studies and an adjusted treatment effect, including the "filled" studies. Funnel plots, plots of the trials' effect estimates against sample size, are skewed and asymmetric in the presence of publication bias and other biases. Funnel plot asymmetry, measured by regression analysis, predicts discordance of results when meta-analyses are compared with single large trials. One of the commonly used regression methods is the Egger method. This method uses a linear regression approach to measure funnel plot asymmetry on the natural logarithm scale of the OR (50) . In this systematic review, we formally investigated the presence of publication bias using a series of publication bias regression and sensitivity plots (e.g., the Egger regression method and the trim and fill method). For the ongoing pregnancy rate, publication bias was found to be unlikely (Egger score = 0.24; 95% CI = í2.19-2.67, P=.83). Even so, using the trim and fill method to determine bias sensitivity revealed that one study (empty circle in Fig. 1B ) may be imputed to bring symmetry to the funnel plot. The resulting meta-analysis outcome would still be significant: OR = 1.50 (95% CI = 1.36-1.65). For the clinical pregnancy rate, publication bias was found to be unlikely (Egger score = 0.21; 95% CI = í1.12-1.54, P=.74). In addition, using the trim and fill method to determine bias sensitivity revealed that no studies need to be imputed to bring symmetry to the funnel plot. Therefore the resulting meta-analysis remains significant: OR = 1.50 (95% CI = 1.38-1.62). The possibility of publication bias opens up the door for questioning the results of any meta-analysis; therefore, further inspection and interpretation are needed to formulate definite conclusions. With regard to the 20 included trials, there was a general trend toward better results with ultrasound guidance, with only a limited number of studies demonstrating equivocal or better results with the clinical touch method. In addition, there was no statistical heterogeneity shown by either the scatter plot or the ǒ 2 / I 2 tests, with regard to the primary outcomes. It may be assumed that studies with equivocal results demonstrate that some clinicians have an excellent clinical sense, therefore nullifying any extra advantage provided by sonographic visualization. Another important issue is the sample size of clinical trials and systematic reviews. It is theorized that some of the smaller trials did not have sufficient sample sizes to detect minor differences between the study groups. The largest included study (N = 800) had enough power to detect an 8% difference in clinical pregnancy rates (16) . Our current meta-analysis included 5,968 ET cycles and could detect an absolute difference of 3.3% with 80% power in a two-tailed analysis (assuming a clinical pregnancy rate of 30% with clinical touch alone and a significance level of .05). The absolute difference between ultrasound-guided and clinical touch ET was 7.7%, therefore validating our results. The number needed to treat to obtain one additional clinical pregnancy with use of ultrasound guidance is 13 (95% CI = 10-19). The exact mechanism whereby ultrasound-guided ET improves pregnancy rates and embryo implantation remains unclear. Several theories have been proposed to identify the mechanisms whereby the transfer technique is optimized. These include confirming the position of the tip of the ET catheter within the uterine cavity, the site of embryo deposition, increasing the frequency of "easy" ETs, and avoiding endometrial indentation (36) . Nevertheless, some clinicians argue that the real benefit of ultrasound guidance lies in the ability to increase the clinical appreciation of the pelvic anatomy during transfer. They infer that ultrasound guidance, compared with the standard clinical touch alone, will not significantly increase the pregnancy rates when ET is performed by experienced professionals. Even so, this simple modification will allow for standardization of the transfer technique and therefore decrease any unexpected variation in pregnancy rates among different clinicians in the same center. Whatever the underlying mechanism, the overall conclusion from this meticulous systematic review is that ultrasound-guided ET with use of 2-D transabdominal ultrasound is significantly more effective than ET by clinical touch alone. It is believed that our overall analysis, and subgroup analyses, represents both a robust evaluation of the available evidence in the medical literature and also the best available evidencebased conclusions to support ultrasound guidance during ET. The results of this systematic review demonstrate that ultrasound guidance during ET placement is a beneficial tool in optimizing the outcome of the ET procedure. This is in line with results of previously published clinical trials, systematic reviews (35, 36) , and published guidelines (53) . In addition, we have demonstrated that the beneficial effect is not limited only to patients with fresh but also those with frozen embryo replacement. It is also hoped that this evidence will be easily and quickly translated from the medical literature to everyday clinical practice. Last, it is also important to note that until today, no study has reported any direct adverse effects of ultrasound-guided ET. Even so, one may argue that the main disadvantages of ultrasound-guided ETs are the need for more time, space, equipment, and trained ultrasound personnel. In addition, possible psychological stress may be caused in some patients who are forced to micturate after the transfer procedure, therefore disrupting the period of absolute bed rest. This issue can be managed easily through proper counseling before the procedure on the amount of time needed for bed rest after ET, which is currently recommended as 20 minutes (53) . Also an additional cost to the transfer cycle may be associated with the preferred usage of echogenic catheters by some clinicians. The manufacturers of ET catheters have began to market new echogenic versions of their standard catheters, which are sold for a 25% to 40% higher price tag than the original product, adding additional costs to the treatment cycle. Even so, it is of the utmost importance to note that even though echogenic catheters promise to be cost-effective by providing clinicians with more ultrasonographic visibility, easier transfers, and higher pregnancy rates than their competitor nonechogenic catheters, these points have not been proved in the literature, apart from more visibility. The pregnancy rates have been equivocal with the echogenic catheters. Therefore echogenicity currently should be left up to individual clinical preference and not standardized. Finally, it would be helpful for clinicians to perform in-house costeffective analyses to determine the best combination of needed equipment, personnel, and catheter choice to provide the most efficient and cost-effective treatment options for patients. In conclusion, according to the best available evidence in the medical literature today, the use of transabdominal ultrasound guidance to guide catheter placement during ET both is beneficial and should become the standard of care for all patients. 
